Stem Cell-Based Approaches in Parkinson's Disease Research

被引：3
作者：
Kim, Min Seong [1 ,2 ,9 ]
Yoon, Subeen [3 ]
Choi, Jiwoo [3 ]
Kim, Yong Jun [3 ,4 ,5 ,8 ]
Lee, Gabsang [1 ,2 ,6 ,7 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, 733 N Broadway, Baltimore, MD 21218 USA
[3] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, 26 Kyungheedae-ro,Dongdaemun-gu, Seoul 02447, South Korea
[4] Kyung Hee Univ, Coll Med, Dept Pathol, Seoul, South Korea
[5] Kyung Hee Univ, Grad Sch, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea
[6] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Med, Dept Neurol, 733 N Broadway, Baltimore, MD 21205 USA
[8] Kyung Hee Univ, Coll Med, Dept Pathol, 26 Kyungheedae, Seoul 02447, South Korea
[9] Sejong Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF STEM CELLS | 2024年
基金：
新加坡国家研究基金会;
关键词：
Disease model; Parkinson disease; Stem cell therapy; Pathological mechanism; MIDBRAIN DOPAMINERGIC-NEURONS; PATHOLOGICAL ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION; NEURAL STEM; FAMILIAL DYSAUTONOMIA; PROGENITOR CELLS; LYSOSOMAL DYSFUNCTION; BRAIN ORGANOIDS; IN-VIVO; LRRK2;
D O I：
10.15283/ijsc23169
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of midbrain dopaminergic neurons, leading to motor symptoms. While current treatments provide limited relief, they don't alter disease progression. Stem cell technology, involving patient-specific stem cell-derived neurons, offers a promising avenue for research and personalized regenerative therapies. This article reviews the potential of stem cell -based research in PD, summarizing ongoing efforts, their limitations, and introducing innovative research models. The integration of stem cell technology and advanced models promises to enhance our understanding and treatment strategies for PD.
引用
收藏
页码：21 / 36
页数：16
相关论文
共 168 条
  • [1] Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects
    Aboud, Asad A.
    Tidball, Andrew M.
    Kumar, Kevin K.
    Neely, M. Diana
    Ess, Kevin C.
    Erikson, Keith M.
    Bowman, Aaron B.
    [J]. NEUROTOXICOLOGY, 2012, 33 (06) : 1443 - 1449
  • [2] A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
    Aflaki, Elma
    Borger, Daniel K.
    Moaven, Nima
    Stubblefield, Barbara K.
    Rogers, Steven A.
    Patnaik, Samarjit
    Schoenen, Frank J.
    Westbroek, Wendy
    Zheng, Wei
    Sullivan, Patricia
    Fujiwara, Hideji
    Sidhu, Rohini
    Khaliq, Zayd M.
    Lopez, Grisel J.
    Goldstein, David S.
    Ory, Daniel S.
    Marugan, Juan
    Sidransky, Ellen
    [J]. JOURNAL OF NEUROSCIENCE, 2016, 36 (28) : 7441 - 7452
  • [3] Cell transplantation in Parkinson's disease: problems and perspectives
    Allan, Laura E.
    Petit, Geraldine H.
    Brundin, Patrik
    [J]. CURRENT OPINION IN NEUROLOGY, 2010, 23 (04) : 426 - 432
  • [4] Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells
    Andersson, Elin K. I.
    Irvin, Dwain K.
    Ahlsio, Jessica
    Parmar, Malin
    [J]. EXPERIMENTAL CELL RESEARCH, 2007, 313 (06) : 1172 - 1180
  • [5] Effect of fetal neural transplants inpatients with Huntington's disease 6 years after surgery:: a long-term follow-up study
    Bachoud-Lévi, AC
    Gaura, V
    Brugières, P
    Lefaucheur, JP
    Boissé, MF
    Maison, P
    Baudic, S
    Ribeiro, MJ
    Bourdet, C
    Remy, P
    Cesaro, P
    Hantraye, P
    Peschanski, M
    [J]. LANCET NEUROLOGY, 2006, 5 (04) : 303 - 309
  • [6] Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease
    Barbuti, Peter A.
    Barker, Roger A.
    Brundin, Patrik
    Przedborski, Serge
    Papa, Stella M.
    Kalia, Lorraine V.
    Mochizuki, Hideki
    [J]. MOVEMENT DISORDERS, 2021, 36 (08) : 1772 - 1780
  • [7] Cell-based therapies for Parkinson disease-past insights and future potential
    Barker, Roger A.
    Drouin-Ouellet, Janelle
    Parmar, Malin
    [J]. NATURE REVIEWS NEUROLOGY, 2015, 11 (09) : 492 - 503
  • [8] Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
    Basellini, Milo Jarno
    Kothuis, Josine Marie
    Comincini, Alessandro
    Pezzoli, Gianni
    Cappelletti, Graziella
    Mazzetti, Samanta
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (02): : 33
  • [9] Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson's Disease Patient
    Becerra-Calixto, Andrea
    Mukherjee, Abhisek
    Ramirez, Santiago
    Sepulveda, Sofia
    Sinha, Tirthankar
    Al-Lahham, Rabab
    De Gregorio, Nicole
    Gherardelli, Camila
    Soto, Claudio
    [J]. CELLS, 2023, 12 (04)
  • [10] Neural transplantation for the treatment of Parkinson's disease
    Björklund, A
    Dunnett, SB
    Brundin, P
    Stoessl, AJ
    Freed, CR
    Breeze, RE
    Levivier, M
    Peschanski, M
    Studer, L
    Barker, R
    [J]. LANCET NEUROLOGY, 2003, 2 (07) : 437 - 445
12345678910